1. Completed
Loading page
Mainboard
Mainboard issue. Listed.
Source: IPO Guru Pro
Company information, issue size, price band, lot size, minimum investment, and the dates published for this issue.
Mankind Pharma Limited was incorporated as Mankind Pharma Private Limited at New Delhi on 3 July 1991. As per IQVIA, it is India's fourth largest pharmaceutical company by domestic sales and the third largest by sales volume for MAT December 2022. It focuses on the Indian market, where it develops, makes and markets formulations across acute and chronic areas such as anti-infectives, cardiovascular, gastrointestinal, anti-diabetic, neuro/CNS, vitamins and respiratory. In consumer healthcare it has brands in condoms, pregnancy detection, emergency contraceptives, antacid powders, vitamin supplements and anti-acne products. Its brands include Manforce, Moxikind-CV, Amlokind-AT, Unwanted-Kit, Prega News, Gudcef and Telmikind. The IPO was Rs 4,326.36 crore and was entirely an offer for sale by the three individual promoters and investors Cairnhill and Beige, so the company received none of the money.
Current premium in rupees, the derived percentage, and the indicative price. History shows observed readings only. A missing premium is unavailable, not ₹0.
Grey Market Premium (GMP) is an unofficial market indicator and is not published by stock exchanges. Estimated listing values are illustrative, may change, and should not be considered a forecast or investment recommendation.
Subscription is shown in times subscribed. A missing multiple stays unavailable. A published zero is 0x.
Last updated: Unavailable
Last updated: Unavailable
Source: IPO Guru Pro Data by IPO Guru
History retrieved: 10 Nov 2026, 3:15 PM IST
No day-wise subscription history is loaded. Missing days are left blank and are not plotted as zero.
Source: IPO Guru Pro. History retrieved 10 Nov 2026, 3:15 PM IST.
Revenue and profit are in rupees for each reporting period. Assets, liabilities, and ratios use the source unit when the statement includes them. Missing figures stay blank.
| Metric (Rs. Crore) | 31 Dec 2022 | 31 Mar 2022 | 31 Dec 2021 | 31 Mar 2021 | 31 Mar 2020 |
|---|---|---|---|---|---|
| Assets | 9,273.75 | 9,147.74 | 8,043.88 | 6,372.63 | 5,073.29 |
| Total Income | 6,777.82 | 7,977.58 | 6,218.29 | 6,385.38 |
Results may still be pending. Check Allotment opens the registrar allotment portal. You may need to select this IPO there. Sign-in is not required.
This is the actual change from the issue price to the listing price. It is separate from the unofficial GMP estimate. A missing price stays unavailable.
RHP, DRHP, and other links that passed the official address check. Unverified addresses are left out.
Data by IPO Guru · Updated
Mankind Pharma is India's fourth largest pharmaceutical company by domestic sales, with prescription brands and consumer healthcare brands such as Manforce and Prega News. Its total income was Rs 7,977.58 crore in FY2022.
Ramesh Juneja, Rajeev Juneja, Sheetal Arora, Ramesh Juneja Family Trust, Rajeev Juneja Family Trust and Prem Sheetal Family Trust
1. Completed
2. Completed
3. Completed
4. Completed
Refund
Demat credit
Indicative only. A GMP-implied price is not a guaranteed listing price.
Unofficial grey-market premium in rupees. Missing observations are not connected and are not drawn as ₹0. This chart is not the listing gain.
High unavailable · Low unavailable
Tap a point for its rupee amount, percentage, and IST time. The table lists the same observations.
Source: IPO Guru Pro. History retrieved 10 Nov 2026, 3:15 PM IST.
| Observed (IST) | GMP (₹) | GMP % | Mark |
|---|---|---|---|
| 08 May 2023, 12:00 PM IST | ₹90 | +8.33% | None |
No intraday GMP history is loaded. Missing slots are not filled in.
High unavailable · Low unavailable
Source: IPO Guru Pro. History retrieved 10 Nov 2026, 3:15 PM IST.
| 5,975.65 |
| Profit After Tax | 1,015.98 | 1,452.96 | 1,260.24 | 1,293.03 | 1,056.15 |
| NET Worth | 7,145.89 | 6,155.23 | 5,965.46 | 4,722.00 | 3,485.31 |
| Total Borrowing | 167.93 | 868.03 | 268.70 | 234.53 | 126.92 |